Suppr超能文献

IGFBP-1 的表达在人 2 型糖尿病肾小球中减少,并调节人足细胞中的 β1-整合素/FAK 信号通路。

IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.

机构信息

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

出版信息

Diabetologia. 2021 Jul;64(7):1690-1702. doi: 10.1007/s00125-021-05427-1. Epub 2021 Mar 24.

Abstract

AIMS/HYPOTHESIS: Podocyte loss or injury is one of the earliest features observed in the pathogenesis of diabetic kidney disease (DKD), which is the leading cause of end-stage renal failure worldwide. Dysfunction in the IGF axis, including in IGF binding proteins (IGFBPs), is associated with DKD, particularly in the early stages of disease progression. The aim of this study was to investigate the potential roles of IGFBPs in the development of type 2 DKD, focusing on podocytes.

METHODS

IGFBP expression was analysed in the Pima DKD cohort, alongside data from the Nephroseq database, and in ex vivo human glomeruli. Conditionally immortalised human podocytes and glomerular endothelial cells were studied in vitro, where IGFBP-1 expression was analysed using quantitative PCR and ELISAs. Cell responses to IGFBPs were investigated using migration, cell survival and adhesion assays; electrical cell-substrate impedance sensing; western blotting; and high-content automated imaging.

RESULTS

Data from the Pima DKD cohort and from the Nephroseq database demonstrated a significant reduction in glomerular IGFBP-1 in the early stages of human type 2 DKD. In the glomerulus, IGFBP-1 was predominantly expressed in podocytes and controlled by phosphoinositide 3-kinase (PI3K)-forkhead box O1 (FoxO1) activity. In vitro, IGFBP-1 signalled to podocytes via β1-integrins, resulting in increased phosphorylation of focal-adhesion kinase (FAK), increasing podocyte motility, adhesion, electrical resistance across the adhesive cell layer and cell viability.

CONCLUSIONS/INTERPRETATION: This work identifies a novel role for IGFBP-1 in the regulation of podocyte function and that the glomerular expression of IGFBP-1 is reduced in the early stages of type 2 DKD, via reduced FoxO1 activity. Thus, we hypothesise that strategies to maintain glomerular IGFBP-1 levels may be beneficial in maintaining podocyte function early in DKD.

摘要

目的/假设:足细胞丧失或损伤是糖尿病肾病(DKD)发病机制中最早观察到的特征之一,DKD 是全球终末期肾衰竭的主要原因。IGF 轴功能障碍,包括 IGF 结合蛋白(IGFBPs),与 DKD 相关,尤其是在疾病进展的早期阶段。本研究的目的是研究 IGFBPs 在 2 型 DKD 发展中的潜在作用,重点是足细胞。

方法

分析了皮马 DKD 队列中的 IGFBP 表达情况,同时分析了 Nephroseq 数据库和体外人肾小球中的数据。在体外研究了条件永生化的人足细胞和肾小球内皮细胞,使用定量 PCR 和 ELISA 分析 IGFBP-1 的表达。使用迁移、细胞存活和粘附测定、电细胞-底物阻抗传感、western blot 和高内涵自动成像研究 IGFBP 对细胞的反应。

结果

皮马 DKD 队列和 Nephroseq 数据库的数据表明,在人类 2 型 DKD 的早期阶段,肾小球 IGFBP-1 显著减少。在肾小球中,IGFBP-1 主要在足细胞中表达,并受磷酸肌醇 3-激酶(PI3K)-叉头框 O1(FoxO1)活性的控制。在体外,IGFBP-1 通过β1-整合素向足细胞发出信号,导致粘着斑激酶(FAK)的磷酸化增加,从而增加足细胞的迁移、粘附、粘附细胞层的电阻和细胞活力。

结论/解释:这项工作确定了 IGFBP-1 在调节足细胞功能中的新作用,并且在 2 型 DKD 的早期阶段,通过减少 FoxO1 活性,肾小球中 IGFBP-1 的表达减少。因此,我们假设维持肾小球 IGFBP-1 水平的策略可能有益于在 DKD 早期维持足细胞功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e41e/8187213/599b557892f1/125_2021_5427_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验